SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 
For the month of December, 2017

Commission File Number 1565025
 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

  Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In November 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(   ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

9,655,277

0.0614

0.0614

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

Shares

Common

Direct with the Company

Conversion in ADRs

03

120,850

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

17

261,000

0.00

0.00

Shares

Common

Direct with the Company

Conversion in ADRs

29

78,890

0.00

0.00

 

 

 

Total Conversion ADRs (Out)

 

460,740

 

0.00

Shares

Common

Direct with the Company

Exerc Options

13

42,325

3.12096

132,094.63

Shares

Common

Direct with the Company

Exerc Options

13

45,175

9.35960

422,819.93

Shares

Common

Direct with the Company

Exerc Options

13

25,385

11.97200

303,909.22

Shares

Common

Direct with the Company

Exerc Options

20

25,385

11.97200

303,909.22

Shares

Common

Direct with the Company

Exerc Options

22

59,750

1.29648

77,464.68

Shares

Common

Direct with the Company

Exerc Options

22

46,000

3.12096

143,564.16

Shares

Common

Direct with the Company

Exerc Options

23

43,900

1.09284

47,975.68

Shares

Common

Direct with the Company

Exerc Options

30

30,125

9.35960

281,957.95

Shares

Common

Direct with the Company

Exerc Options

30

63,465

11.97200

759,802.98

Shares

Common

Direct with the Company

Exerc Options

30

77,665

17.19800

1,335,682.67

 

 

 

Total Sell

 

459,175

 

3,809,181.12

 

 

 

 

 

 

 

 

Shares

Common

Direct with the Company

Plan of Shares Acquisition

13

42,474

20.22

858,824.28

Shares

Common

Direct with the Company

Plan of Shares Acquisition

20

14,796

20.54

303,909.84

Shares

Common

Direct with the Company

Plan of Shares Acquisition

21

30,000

20.81

624,300.00

Shares

Common

Direct with the Company

Plan of Shares Acquisition

30

115,636

20.56

2,377,476.16

 

 

 

Total Buy

 

202,906

 

4,164,510.28

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

8,938,268

0.0569

0.0569

                       

 

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)       Quantity multiplied by price .


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In November 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price USD

Volume (USD) (3)

ADR (*)

Common

Direct with the Company

Conversion in ADRs

03

120,850

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

17

261,000

0.00

0.00

ADR (*)

Common

Direct with the Company

Conversion in ADRs

29

78,890

0.00

0.00

 

 

 

Total Conversion ADRs (In)

 

460,740

 

0.00

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Plan of Shares Acquisition

29

76,135

6.30

479,647.35

 

 

 

Total Buy

 

76,135

 

479,647.35

ADR (*)

Common

Direct with the Company

Exerc Options

03

36,900

0.000000

0.00

ADR (*)

Common

Direct with the Company

Exerc Options

03

44,475

1.130456

50,277.03

ADR (*)

Common

Direct with the Company

Exerc Options

03

39,475

2.234470

88,205.70

ADR (*)

Common

Direct with the Company

Exerc Options

17

59,250

1.248396

73,967.46

ADR (*)

Common

Direct with the Company

Exerc Options

17

110,500

0.000000

0.00

ADR (*)

Common

Direct with the Company

Exerc Options

17

53,350

1.130456

60,309.83

ADR (*)

Common

Direct with the Company

Exerc Options

17

37,900

2.234470

84,686.41

ADR (*)

Common

Direct with the Company

Exerc Options

29

155,025

3.094000

479,647.35

 

 

 

Total Sell

 

536,875

 

837,093.78

 

 

 

 

 

 

 

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

                       

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 


 

(3)       Quantity multiplied by price .

 

(*)    Each ADR is equivalent to 1 (one) share.

 

 

 

 

 

 

 

 

 

 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In November 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Subsidiary Name: Ambev Luxembourg S.À.R.L.

Qualification: Position – Total Return Swap

Transac tions in the month

Securities / Derivatives

Securities Characteristics (1)

Intermediary

Operation

Day

Quantity (**)

Price USD

Volume (USD) (2)

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

06 (*)

1,215,000

20.5670

24,988,905.00

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

08 (*)

221,000

20.0475

4,430,497.50

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

10 (*)

291,500

20.0330

5,839,619.50

 

 

 

Total operation

 

1,727,500

 

35,259,022.00

 

(1)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(2)       Quantity multiplied by price .

 

 

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

 

(**) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: December 8, 2017
     
 
AMBEV S.A.
     
 
By: 
/s/ Ricardo Rittes de Oliveira Silva
 
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
 
 
 
 

Ambev (NYSE:ABEV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ambev Charts.
Ambev (NYSE:ABEV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ambev Charts.